Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant-Reference-Cited by-同舟云学术

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant

Published:1999-10 Issue:10 Volume:27 Page:1477-1486
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Dazzi Francesco,Szydlo Richard M,Goldman John M

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference90 articles.

1. Chronic myeloid leukemia;Deininger;Curr Opin Hematol,1998

2. Antibody recognition of the tumor-specific b3-a2 junction of bcr-abl chimeric proteins in Philadelphia-chromosome-positive leukemias;van Denderen;Leukemia,1992

3. The involvement of tumor suppressor p53 in normal and CML hemopoiesis;Bi;Cancer Res,1994

4. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia;Sill;Blood,1995

5. Interferon alpha versus chemotherapy for chronic myeloid leukemia;J Natl Cancer Inst,1997

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT;American Journal of Hematology;2022-10-31

2. Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis;Leukemia & Lymphoma;2022-09-13

3. CAR‐T cell therapy in paediatric acute lymphoblastic leukaemia – past, present and future;British Journal of Haematology;2020-11

4. The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer;Cell Proliferation;2020-03

5. Allogeneic Haematopoietic Stem Cell Transplantation for Chronic Myeloid Leukaemia in the Era of Tyrosine Kinase Inhibitors;EMJ Hematology;2018-08-02